Thromboembolic and hemorrhagic risks after vaccination against SARS-CoV-2: a systematic review and meta-analysis of randomized controlled trials.
Noppacharn UaprasertKrissana PanrongPonlapat RojnuckarinThita ChiasakulPublished in: Thrombosis journal (2021)
Vaccines against SARS-CoV-2 are not associated with an increased risk of thromboembolism, hemorrhage, and thromboembolism/hemorrhage-related death.